von Willebrand Factor Activity (Ristocetin Cofactor)
Ristocetin cofactor is used in the diagnosis of von Willebrand disease and in the measurement of the response to therapy. Von Willebrand disease is the most frequent inherited autosomal dominant trait bleeding disorder. Early evidence of the disease is noted by easy bruising and prolonged bleeding especially from mucosal surfaces. This test is very sensitive and results are decreased in almost all types of the disease; however, some forms of type 2b will show normal results and further testing is necessary to confirm the diagnosis. Type 2b accounts for approximately 20% of all cases. In the presence of von Willebrand factor, ristocetin will induce platelet agglutination. The principle of testing includes addition of the patient’s plasma to control platelets and ristocetin. The agglutination is measured and the degree of agglutination is determined by the concentration and function of von Willebrand factor.
Von Willebrand factor is synthesized by endothelial and megakaryocytic cells. A noted importance of the disease evaluation depends on the patient’s blood type. A higher concentration of the vWF antigen is seen in AB blood types whereas patients with type O are known to have the lowest amount. This is important because the interpretation can be misdiagnosed if the blood type is not known.
- Diagnostic measurement in the response to therapy in vWD
- Used to diagnose von Willebrand Disease
Increased in:
- Liver disease
- Pregnancy
- Estrogen therapy
- Exercise
Decreased in:
- von Willebrand Disease
| Blood Type | Reference Range (U/dL) |
| Blood type O | 50–150 |
| Blood type non-O | 90–200 |
Plasma Citrate (Light Blue)
Freeze immediately and maintain frozen until tested.
Stability
- Ambient: 4 hr
- Refrigerated: Unacceptable
- Frozen: 14 days
- Clin Chem. 1995 Apr;41(4):489-90. [PMID: 7720235]
- Semin Thromb Hemost. 2002 Apr;28(2):161-6. [PMID: 11992239]
- Haematologica. 2004 Jan;89(1):77-85. [PMID: 14754609]
- Int J Hematol. 2002 Jan;75(1):9-18. [PMID: 11843298]
- CLSI document: Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline. ISBN 1-56238-473-2, H51-A, volume 22.